Cullen/Frost Bankers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
DCP
SIMG
Cullen/Frost Bankers's DXCM Position: Q2 2026 in Review
Cullen/Frost Bankers increased its DexCom (DXCM) stake by 0.87% in Q2 2026, buying an estimated $4.4K and bringing the position to 7,644 shares worth $515K. The position accounts for 0.01% of the portfolio, ranked #440.
Cullen/Frost Bankers first reported a position in DXCM in Q4 2019 and has held it in 16 quarters since. The position peaked at $548K in Q2 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Cullen/Frost Bankers held 7,644 shares of DexCom worth $515K as of Q2 2026.
- Cullen/Frost Bankers bought 66 DexCom shares in Q2 2026, an estimated $4.4K.
- DexCom made up 0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #440 holding.
- Cullen/Frost Bankers first reported a position in DexCom in Q4 2019 and has held it in 16 quarters since.
- Cullen/Frost Bankers's DexCom position peaked at $548K in Q2 2025.
- 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.